Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-02-16
1998-02-03
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
A61K 9127, A61K 9133
Patent
active
057141630
ABSTRACT:
A liposome formulation containing a Vinca Alkaloid and an ion in an aqueous phase of the liposome. The liposomes also comprise distearoylphosphatidyl choline, cholestrol and disteraroylphosphatidylglycerol. A method for enhancing the efficacy and tumor targeting properties of liposomal vinca alkaloid formulations containing unilamellar vesicles.
REFERENCES:
patent: 5019369 (1991-05-01), Present et al.
patent: 5316771 (1994-05-01), Barenholz et al.
Boman, N.L. et al., "Optimization of the retention properties of vincristine in liposomal systems." Biochimica et Biophysica Actd., 1152:pp253-258 (1993).
Boman, N.L. et al., "Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors." Cancer Research 54:pp2830-2833 (Jun. 1, 1994).
Mayer, L.D. et al., "Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia." Cancer Chemother Phamacol 33:17-24(199
Vaage, J. et al., "Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes." Int. J. Cancer 54:959-964 (1993).
Forssen, E. et al., "Liposome-entrapped vincristine and mitomycin-C for treatment of solid tumors: i vivo efficacy as a function of co-entrapped counterion." Scientific Proceedings American Association for Cancer Research. 34:365 (1993) Abstract 2176.
Layton, D. et al., "A comparison of the therapeutic effects of free and liposomally encapsulated vincristine in leukemic mice." Europ. J. Cancer 16:945-950 (1980).
Cox Gerry
Forssen Eric
Hair Dennis
Kishore Gollamudi S.
NeXstar Pharmaceuticals, Inc.
LandOfFree
Vinca alkaloid vesicles with enhanced efficacy and tumor targeti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vinca alkaloid vesicles with enhanced efficacy and tumor targeti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinca alkaloid vesicles with enhanced efficacy and tumor targeti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-660061